Spontaneous HNSCC Model and Therapy
Corresponding Organization : Peking University
Variable analysis
- ASO PVT1 (10 nM, Integrated Biotech Solutions Co., Ltd, Shanghai, China)
- ASO NC (control)
- Anti-PD1 (BioXcell, Lebanon, NH, USA, 200 μg/mouse)
- Lesion surface areas of tongue
- SCC (Squamous Cell Carcinoma) number and invasiveness in tongue
- Cervical lymph node metastasis of HNSCC
- Bmi1CreER; RosatdTomato mice
- 4NQO treatment for 16 weeks followed by 6 weeks of normal drinking water to develop spontaneous HNSCC
- Tamoxifen administration to label Bmi1+ CSCs
- Positive control: ASO NC (control)
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!